Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis method offers high enantioselectivity and scalable production for pharmaceutical intermediates supply chain optimization and cost efficiency.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108395412A reveals a novel Rh-catalyzed synthesis for triazole derivatives, offering streamlined production and cost advantages for pharmaceutical and agrochemical supply chains.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production. Scalable process offers significant cost and supply chain advantages for global pharmaceutical partners.
Patent CN115304557B reveals cost-effective manganese catalysis for enamine derivatives, offering supply chain stability and reduced manufacturing costs for pharmaceutical intermediates.
Novel iridium-catalyzed method offers high enantioselectivity. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel chiral phosphoric acid catalysis for indoline pyrroles. High ee, mild conditions. Reliable supplier for anticancer intermediates.
Novel chiral phosphoric acid catalysis enables high-yield synthesis of anticancer intermediates. Scalable production offers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Novel heterogeneous catalytic method for benzimidazole synthesis offering mild conditions and recyclable catalysts for cost-effective production.
Patent CN111285846B details a novel Rh-catalyzed C-H activation route for 2-(2-indolyl)-acetates, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN118638038B reveals novel chiral isothiourea catalysis for high-purity indole amides. Enables cost reduction and scalable supply chain for pharmaceutical intermediates manufacturing.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Novel nitrile hydratase method for Eluxadoline intermediate offers high yield and mild conditions, ensuring reliable supply chain and cost efficiency.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Novel synthesis method for N-N axis chiral compounds delivering high ee and mild conditions. Reliable supplier for pharma intermediates ensuring cost reduction.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Novel photocatalytic method for cyanosulfonyl fluoride compounds offers efficient synthesis and supply chain advantages for pharmaceutical intermediates manufacturing globally.
Novel metal-free synthesis of pyrimidoindazoles via one-pot cascade. High yields, mild conditions, ideal for API intermediates and kinase inhibitor development.
Patent CN117720537B reveals a novel indole-furan catalyst enabling high-purity asymmetric synthesis with significant cost reduction in fine chemical manufacturing and supply chain reliability.